Bobilev Dmitri 4
4 · Fusion Pharmaceuticals Inc. · Filed Nov 7, 2022
Insider Transaction Report
Form 4
Bobilev Dmitri
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-07+550,000→ 550,000 totalExercise: $1.98Exp: 2032-11-07→ Common Stock (550,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest and become exercisable on the first anniversary the grant date and the remainder shall vest and become exercisable in 36 substantially equal monthly installments thereafter.